These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12218956)

  • 41. Long-term effects of low-dose 17beta-estradiol plus dydrogesterone on 24-h ambulatory blood pressure in healthy postmenopausal women: a 1-year, randomized, prospective study.
    Kaya C; Cengiz SD; Cengiz B; Akgun G
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():62-7. PubMed ID: 17943541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
    Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic american Indian women: the strong heart study.
    Zhang Y; Howard BV; Cowan LD; Welty TK; Schaefer CF; Wild RA; Yeh J; Lee ET
    J Womens Health (Larchmt); 2004 Mar; 13(2):155-63. PubMed ID: 15072729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels.
    Sieminska L; Wojciechowska C; Niedziolka D; Marek B; Kos-Kudla B; Kajdaniuk D; Nowak M
    Metabolism; 2005 Dec; 54(12):1610-4. PubMed ID: 16311093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
    Kwok S; Selby PL; McElduff P; Laing I; Mackness B; Mackness MI; Prais H; Morgan J; Yates AP; Durrington PN; Sci FM
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):760-7. PubMed ID: 15579192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of hormone replacement therapy on blood coagulation and fibrinolysis in hypertensive and normotensive postmenopausal women.
    Sumino H; Ichikawa S; Sawada Y; Sakamoto H; Kumakura H; Takayama Y; Sakamaki T; Kurabayashi M
    Thromb Res; 2005; 115(5):359-66. PubMed ID: 15733968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hormone replacement therapy in women with arterial hypertension in peri- and postmenopause: hemodynamic effects].
    Bystrova MM; Britov AN; Gorbunov VM; Lebedev AV; Eliseeva NA; Smetnik VP; Slasten OP
    Ter Arkh; 2001; 73(10):33-8. PubMed ID: 11763512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects on climacteric symptoms, bone and lipoprotein metabolism of hormone replacement therapy delivered by estradiol-releasing intravaginal rings: a pilot study.
    Farish E; Barnes JF; Rankin M; Hart DM
    Climacteric; 2003 Sep; 6(3):211-20. PubMed ID: 14567769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: a randomised controlled trial.
    de Kraker AT; Kenemans P; Smolders RG; Kroeks MV; van der Mooren MJ
    Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):139-44. PubMed ID: 19095343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beneficial influence of postmenopausal estrogen therapy on serum adhesion molecules is independent of the route and dose of administration.
    Rajtar-Ciosek A; Huras H; Krzysiek J; Reroń A; Wilczak M; Jach R
    Neuro Endocrinol Lett; 2011; 32(3):340-4. PubMed ID: 21670727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Medication of the month. Femoston Low (0.5 mg estradiol plus 2.5 mg dydrogesterone) for menopausal hormonal replacement therapy].
    Scheen AJ; Gaspard U
    Rev Med Liege; 2011 Apr; 66(4):209-14. PubMed ID: 21638840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thoughts on individualizing hormone replacement therapy based on the postmenopausal health disparities study data.
    Gavaler JS
    J Womens Health (Larchmt); 2003 Oct; 12(8):757-68. PubMed ID: 14588126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role.
    Dafopoulos K; Kotsovassilis CG; Milingos S; Kallitsaris A; Galazios G; Zintzaras E; Sotiros P; Messinis IE
    Hum Reprod; 2004 Sep; 19(9):1985-92. PubMed ID: 15229199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transdermal estrogen replacement therapy in normal perimenopausal women: effects on pituitary-ovarian function.
    De Leo V; Lanzetta D; D'Antona D; De Palma P
    Gynecol Endocrinol; 1996 Feb; 10(1):49-53. PubMed ID: 8737192
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical experiences with Climen in peri- and postmenopausal women].
    Husmann F
    Zentralbl Gynakol; 1997; 119(3):123-7. PubMed ID: 9173770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.